Neurogene Inc. (NGNE) has released an update.
Neurogene Inc., a biotech firm listed on The Nasdaq Global Market under the ticker NGNE, has recently filed a Form 8-K with the SEC. The report details the company’s latest updates, which are crucial for investors tracking Neurogene’s performance and strategic developments. Based in New York, the company continues to adhere to regulatory requirements, ensuring transparency in its operations.
For further insights into NGNE stock, check out TipRanks’ Stock Analysis page.
